Colorectal Cancer
Copyright ©The Author(s) 2003.
World J Gastroenterol. May 15, 2003; 9(5): 961-964
Published online May 15, 2003. doi: 10.3748/wjg.v9.i5.961
Table 1 Basic demographic data for the study groups of patients with colorectal cancer
Number362137475
Mean age-years69 (± 12)70 (± 11)69 (± 13)
Age range-years29 to 9338 to 9332 to 95
Sex ration M:F1.3:11.4:11.4:1
ASA score of 3 or 440%39%22%
Elective vs emergency319 vs 43112 vs 25394 vs 81
procedures(88% vs 12%)(78% vs 18%)(79% vs 17%)
Curative vs palliative264 vs 80101 vs 23366 vs 85
pesections(73% vs 22%)(74% vs 17%)(77% vs 18%)
No surgery18 (5%)13 (9%)24 (5%)
Colon cancer170 (47%)a90 (66%)314 (66%)
Rectal cancer192 (53%)b47 (34%)161 (34%)
Adjuvant chemotherapy116 (32%)c19 (14%)17 (4%)
Adjuvant radiotherapy65 (18%)d9 (7%)14 (4%)
Mean follow-up-years2.75 (± 1.2)e4.5 (± 1.4)5.1 (± 4.5)
Max follow-up-years6.86.913.9
Table 2 Staging information for colorectal cancers for the study groups
StageColorectal group number (%)General surgical group number (%)Historical group number (%)
Stage I81 (22%)a9 (7%)57 (12%)
Stage II95 (26%)b53 (39%)159 (33%)
Stage III91 (25%)41 (30%)146 (31%)
Stage IV91 (25%)29 (21%)106 (22%)
Stage unknown4 (1%)4 (3%)7 (2%)
Table 3 A comparison of the overall 5 year survival based on stage for the study groups
StageColorectal groupGeneral surgical groupHistorical group
I90%a67%72%
II62%57%58%
III60%b46%34%
IV (2 year survivals)22%21%19%
Table 4 Cox survival regression analysis of independent predictors of the overall survival in the 974 patients with colorectal cancer
Independent variablesPHazard ratio95% Confidence interval
Age0.151.0111.002-1.020
ASA score< 0.00011.4771.29-1.69
Adjuvant chemotherapy0.0470.6340.405-0.993
Stage I< 0.00010.2110.107-0.418
Stage II0.0030.3970.214-0.738
Stage III0.190.6650.358-1.237
Stage IV0.0092.271.229-4.186
Colorectal surgical unit vs control0.00050.6670.531-0.837